Important: To support fast and efficient fulfillment, Southern Aminos may maintain inventory from multiple active batches of the same product. Orders are fulfilled using the available inventory at the time of processing; therefore, we cannot guarantee or accommodate requests for a specific batch. Please be assured that every active batch has undergone thorough testing and has passed all required quality-control standards before being released for sale.
CJC-1295/IPAMORELIN Certificates of Analysis
ALL BATCHES ARE THIRD-PARTY INDEPENDANTLY TESTED
8X TestingThird-Party VerifiedHighest Standards
| Product | Batch | COA Date | Cap/Crimp | Average Mass (mg) |
Average Purity (%) |
8X Testing (8 Tests) |
Status | COA Reports |
|---|---|---|---|---|---|---|---|---|
| CJC-1295/IPAMORELINResearch Use Only | CJIP0626J | Jun 26, 2026ILS Labs | Blue / Silver | 10.41 mg10.26–10.65 mg8 vials tested | 99.82%99.68–99.95%8 vials tested | 8 / 8 Tested | PASSED | View COA (PDF) |
Vial ResultsPurity Results8X Testing ResultsBatch Information
Individual Vial Mass (mg)Vial 110.48Vial 210.63Vial 310.26Vial 410.31Vial 510.65Vial 610.27Vial 710.3Vial 810.39 Individual Vial Purity (%)Vial 199.68Vial 299.74Vial 399.72Vial 499.9Vial 599.85Vial 699.89Vial 799.95Vial 899.8 8X Testing ResultsIdentity Purity Conformity Endotoxin Sterility Heavy Metals Fentanyl Conformity Mass Batch Information
|
CJC-1295 (No DAC) + Ipamorelin 10mg/10mg – Research Combination (Laboratory Use Only)
Description:
The CJC-1295 (No DAC) + Ipamorelin blend is a laboratory-grade peptide combination formulated for controlled in-vitro research.
-
CJC-1295 (No DAC) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) that promotes transient GH secretion without extended half-life modification, enabling precise short-term experimental modeling.
-
Ipamorelin is a selective GH secretagogue that interacts with ghrelin receptors to influence GH release dynamics and associated anabolic pathways.
Specifications
-
Unit Size: 10mg CJC-1295 (No DAC) + 10mg Ipamorelin (10mg total)
-
Form: Lyophilized powder
-
Storage: Store in a cool, dry environment.
Intended Use
All Southern Aminos peptides are supplied exclusively for in-vitro laboratory research use.
This compound is not intended for human or animal use, and must not be utilized in therapeutic, diagnostic, dietary, or cosmetic applications.
Legal Disclaimer
This material has not been evaluated by the U.S. Food and Drug Administration (FDA).
Products and statements from Southern Aminos are not intended to diagnose, treat, cure, or prevent any disease.
Use is limited to qualified researchers and laboratory professionals conducting lawful, compliant scientific studies.
Terms of Sale
All sales are final.
By purchasing from Southern Aminos, the buyer affirms they are a qualified professional or laboratory entity responsible for safe handling, storage, and use in accordance with local, state, and federal research regulations.
Southern Aminos – Research Use Policy & Liability Disclaimer
The products offered by Southern Aminos are intended strictly for laboratory research use only and are sold exclusively to qualified professionals, institutions, and research entities.
All materials are not for human consumption, veterinary use, or any application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes.
By purchasing from Southern Aminos, you acknowledge and agree that:
-
You are a qualified professional or research institution with the proper knowledge, training, and facilities to safely handle and store laboratory-grade reagents and peptides.
-
You will use all products in full compliance with local, state, and federal laws and regulations governing laboratory research materials.
-
You accept full responsibility for the safe handling, storage, and lawful use of any material purchased from Southern Aminos.
Prohibited Uses
-
Products sold by Southern Aminos must not be used as active pharmaceutical ingredients (APIs) in the compounding or manufacturing of drugs for human or veterinary purposes.
-
Products must never be administered to humans or animals under any circumstances.
-
Southern Aminos does not condone, support, or permit the use of its products in the development, testing, or production of illegal or controlled substances.
Regulatory Compliance
Southern Aminos makes no representation or warranty that any product has been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory body.
Statements regarding any product are for informational and educational purposes only and have not been evaluated by the FDA.
Our products are not intended to diagnose, treat, cure, or prevent any disease and are sold solely for qualified research applications.
Liability Statement
The buyer assumes full responsibility for the proper handling, storage, and lawful use of any product purchased from Southern Aminos.
Southern Aminos shall not be held liable for any damages, losses, or injuries—direct or indirect—arising from misuse, mishandling, or unauthorized application of its products.
Southern Aminos also reserves the right to refuse or cancel sales to any individual or entity suspected of misusing research materials or violating applicable regulations.
If you have questions regarding the safe or lawful use of Southern Aminos research materials, please consult a qualified laboratory professional prior to purchase.
By completing a transaction with Southern Aminos, you agree to all terms, conditions, and policies outlined in this statement.
CJC-1295 (with and without DAC)
| Attribute | Details |
|---|---|
| Type | Synthetic GHRH analog |
| Sequence Length | 30 amino acids |
| Molecular Weight | ~3368 Da (without DAC), ~3647 Da (with DAC) |
| Mechanism | Binds GHRH receptors → stimulates pituitary GH release |
| DAC Function | Albumin-binding → extends half-life to 6–8 days |
| Half-Life | ~30 minutes (no DAC), ~6–8 days (with DAC) |
| Delivery | Subcutaneous injection (lyophilized powder for reconstitution) |
| Primary Effects | Pulsatile GH release, IGF-1 elevation, lean mass gain, fat loss |
| Clinical Data | Dose-dependent GH increase (2–10x), 5–8% fat loss, 7% bone density gain |
| Regulatory Status | Not FDA-approved; research use only |
Ipamorelin
| Attribute | Details |
|---|---|
| Type | Synthetic pentapeptide; selective GH secretagogue |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NHâ‚‚ |
| Molecular Weight | ~711 Da |
| Mechanism | Binds ghrelin receptor (GHS-R1a) → stimulates GH release without cortisol |
| Selectivity | Highly selective for GH; minimal impact on prolactin, ACTH, cortisol |
| Half-Life | ~2 hours |
| Delivery | Subcutaneous injection (lyophilized powder) |
| Primary Effects | GH pulse stimulation, lean mass gain, recovery enhancement |
| Clinical Data | Well-tolerated; no significant desensitization or hormonal disruption |
| Regulatory Status | Not FDA-approved; research use only |
The products available here are designed exclusively for research and laboratory use. They are not approved for human or animal consumption. These items are not classified as medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Not for clinical, diagnostic, or therapeutic use. The product page photos are representative images only and are not intended to reflect the exact batch specifications for every shipment. We are a large peptide business and run multiple batches per product, all current batches are listed on the product page, we are unable to provide batch specific requests, and there should be no expectation that you will receive any current specific batch. Product images are for illustrative purposes only. Actual labels, packaging, and product color may vary.

